Anti-IFN-α1/2/13 Antibody (ST29) is a mouse monoclonal IgG1 (kappa light chain) IFN-α1/2/13 antibody provided at 200 µg/ml
raised against human IFN-α
recommended for detection of IFN-α subtypes 1, 2 and 13 of human origin by functional assay
also provided azide-free for neutralization, sc-53341 L, 200 µg/0.1 ml
m-IgG Fc BP-HRP is the preferred secondary detection reagent for IFN-α1/2/13 Antibody (ST29) for WB and IHC(P) applications. This reagent is now offered in a bundle with IFN-α1/2/13 Antibody (ST29) (see ordering information below).
Every item is shipped based on the best shipping method assessed for the temperature requirements of that specific item. Items are grouped and shipped together whenever
possible, and a separate shipping charge will be included for each shipping method required. Shipping charges listed below are from our US warehouses to the Contiguous US,
Alaska, Hawaii, Canada and Puerto Rico. Shipping charges for countries outside the US and Canada will be determined once order has been received
Please note: We can not ship to PO boxes
Express Blue Ice
Express Dry Ice
Animal Health Prescription Item
SHIPPING METHODS & CHARGES
Ships via FedEx Ground to Contiguous US, Alaska, Canada, Monday through Friday. This method is used for less temperature sensitive items such as lab ware and animal
health products, bulky and/or heavy items
Labware ships FedEx Ground free of charge to the contiguous US
IFN-α1/2/13 Antibody (ST29) is a high quality monoclonal IFN- alpha 1/2/13 antibody (also designated IFN-α1/2/13 antibody) suitable for the detection of the IFN- alpha 1/2/13 protein of human origin. IFN-α1/2/13 Antibody (ST29) is available as the non-conjugated anti-IFN- alpha 1/2/13 antibody. The genes encoding type I interferons (IFNs), which include 14 IFN-α genes (such as IFN-α1, IFN-α2 and IFN-α13), 1 IFN-β gene, 1 IFN-w (also known as IFN-α II1) gene and a number of IFN-w pseudogenes, are clustered on human chromosome 9. IFN-α and -β are cytokines that are widely known to induce potent antiviral activity. They exert a variety of other biological effects, including antitumor and immunomodulatory activities and are increasingly used clinically to treat a range of malignancies, myelodysplasias and autoimmune diseases. IFN-w is antigenically different from human IFN-α, IFN-β or IFN-γ, but is a component of natural mixtures of IFN species produced by virus-induced leukocytes or Burkitt′s lymphoma cells. The type I interferon receptor (IFN-αR) interacts with IFN-α, IFN-β and IFN-w, and seems to be a multisubunit receptor.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.